Applied Therapeutics Inc (NASDAQ:APLT) currently has a daily average trading volume of 3.51M but it saw 1829467 shares traded in last market. With a market cap of 51.32M USD, the company’s current market price of $0.44 came falling about -4.15 while comparing to the previous closing price of $0.46. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.62 and as low as $0.43. In the recent trading on the day, stock has struck highest price mark of $0.435 while lowest mark touched by it was $0.4641.
Taking a look at 20-day trading activity of Applied Therapeutics Inc (APLT) gives us an average price of $0.5196, while its current price level is -95.85% below from 52-week high level whereas it is 1.84% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5478 while that of 200 days or SMA-200 reads an average of $4.3038. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.01% during that period while stretching the period over a month that increases to 11.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 35.71 which implies that the stock is in neutral territory.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 02, 2024 while assigning a price target range of $13-$2. RBC Capital Mkts also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $12 and $4.
Over the week, APLT’s stock price is moving -15.73% down while it is -8.51% when we observe its performance for the past one month. Year-to-date it is -48.49% down and over the past year, the stock is showing a downside performance of -93.03%.
The company is expected to be releasing its next quarterly report on 2025-Mar-17, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -1.33. In next quarter, company is expected to be making quarterly sales of $12.32M as analysts are expecting the sales for current fiscal year at $553k and seeing the company making $15.14M in sales next year. Moreover, analysts are in estimates of $100k for current-quarter revenue.
Currently, Applied Therapeutics Inc’s total number of outstanding shares is 116.36M with 6.47% of that held by the insiders while 107.37% of its common stock has been owned by the institutions. Stock’s beta reads 1.99. Stock has a price to book (P/B) ratio of 8.71.
